Investment

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Oak Street Health, Inc. – OSH

NEW YORK, Feb. 20, 2022 — Pomerantz LLP is investigating claims on behalf of investors of Oak Street Health, Inc. Such investors are advised to contact Robert S. Willoughby.

The investigation concerns whether Oak Street and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

On November 8, 2021, Oak Street filed its quarterly report with the U.S. Securities and Exchange Commission on Form 10-Q for the quarter ended September 30, 2021. Therein, Oak Health disclosed, in relevant part, that on November 1, 2021 the Company received a civil investigative demand (“CID”) from the United States Department of Justice (“DOJ”).

On this news, Oak Street’s stock price fell $9.75 per share, or more than 20%, to close at $37.14 per share on November 9, 2021.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members.

Image Courtesy Pomerantz

This article was shared with Prittle Prattle News as a Press Release by PRNewswire

Related Posts

1 of 62